'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Gaudium IVF and Women Health Limited
GAUDIUMIVF (NSE) · GAUDIUMIVF (BSE 544709) · ISIN INE0P8B01020 · Healthcare Service Provider · Est. 2015 · listed 2026 · website
Not on any surveillance list
In Q1 FY27 (quarter to 30 June 2026, standalone), revenue was ₹13.68 cr and profit after tax ₹1.66 cr.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q1 FY27 standalone | ₹13.68 cr | ₹1.66 cr | 0.23 | 13 Aug 2026 |
| Q4 FY26 standalone | ₹22.17 cr | ₹7.73 cr | 1.24 | 29 May 2026 |
| Q3 FY26 standalone | ₹14.19 cr | ₹3.18 cr | 0.52 | 18 Mar 2026 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹149.26 cr | ₹21.1 cr | ₹178.59 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 71.29% | 1.19% | 2.22% | 28.71% |
Latest filings
- Annual Report FY2025-26 (New) 3 September 2026 · NSE
- Gaudium IVF and Women Health Limited has informed the Exchange about Transcript of Earnings Call on Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. 19 August 2026 · NSE
- Gaudium IVF and Women Health Limited has informed the Exchange about Audio recording of the Earnings Call on the Financial Results for the quarter ended June 30, 2026. 14 August 2026 · NSE
- Gaudium IVF and Women Health Limited has informed the Exchange about Investor Presentation 14 August 2026 · NSE
- Gaudium IVF and Women Health Limited has informed the Exchange about Investor Presentation 13 August 2026 · NSE
Other companies in Healthcare Service Provider
- Dr. Lal Path Labs Ltd.
- Metropolis Healthcare Limited
- Thyrocare Technologies Limited
- Vijaya Diagnostic Centre Limited
- Krsnaa Diagnostics Limited
- One Global Service Provider Limited
- Nephrocare Health Services Limited
- Suraksha Diagnostic Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.